  |
|
|
 |
CAMR RECOGNIZES EMBRYONIC STEM CELL INFLUENCE IN CERTAIN ELECTION WINS
The voters have spoken. It's clear that Americans took their feelings about embryonic stem cell research to the polls yesterday. We are pleased to see that so many candidates supporting embryonic stem cell research were re-elected or elected for the first time to both the U.S. Senate and House of Representatives. This shows great promise for the future of federal embryonic stem cell legislation, and we look forward to working with elected officials on both sides of the aisle to bring about policy initiatives that will move America forward in the fields of science and medicine.
We believe that pro-embryonic stem cell positions played a positive and decisive role in the election or re-election of candidates such as pro-stem cell Maryland Senator Ben Cardin and pro-stem cell Missouri Senator Claire McCaskill, to name a few. And, we are pleased that stalwart stem cell champions Rep. Mike Castle (R-DE) and Rep. Diana DeGette (D-CO), as well as Senators Orrin Hatch (R-UT), Ted Kennedy (D-MA), and Dianne Feinstein (D-CA) were re-elected and are coming back to Washington in January.
Thanks to the advocacy efforts of Michael J. Fox and the millions of Americans affected with debilitating diseases and disorders for which embryonic stem cell research provides hope for better treatments and cures, the issue of stem cell research stayed on the front burner this election cycle. We look forward to working with the U.S. House and Senate in 2007 to bring forth legislation that will provide federal funding for embryonic stem cell research. Americans who themselves or whose families are impacted by cancer, diabetes, Parkinson's, Alzheimer's, spinal cord injuries and other diseases and disorders let their voices be heard, and for that, we are grateful.
Sean Tipton
President, CAMR
|
|
|
|
  |